Predictive Oncology Share Holder Equity 2010-2025 | POAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Predictive Oncology share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Predictive Oncology share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.2B
Doximity (DOCS)	$11.7B
Hims & Hers Health (HIMS)	$11.6B
Tempus AI (TEM)	$10.4B
IRhythm Technologies (IRTC)	$4.4B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$1.7B
Phreesia (PHR)	$1.6B
Schrodinger (SDGR)	$1.6B
Clover Health Investments (CLOV)	$1.5B
10x Genomics (TXG)	$1.5B
Azenta (AZTA)	$1.5B
Evolent Health (EVH)	$1.3B
Omnicell (OMCL)	$1.3B
Claritev (CTEV)	$725M
Fulgent Genetics (FLGT)	$549M
Veradigm (MDRX)	$499M
Standard BioTools (LAB)	$471M
Butterfly Network (BFLY)	$443M
Talkspace (TALK)	$416M
TruBridge (TBRG)	$326M
Outset Medical (OM)	$321M
Nyxoah SA (NYXH)	$271M
Health Catalyst (HCAT)	$264M
SOPHiA GENETICS SA (SOPH)	$241M
CapsoVision (CV)	$221M
Zepp Health (ZEPP)	$188M
KORU Medical Systems (KRMD)	$144M